Detalhe da pesquisa
1.
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.
N Engl J Med
; 386(3): 220-229, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045228
2.
Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool.
J Infect Dis
; 228(10): 1452-1455, 2023 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540090
3.
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
Clin Infect Dis
; 72(12): 2132-2140, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32255488
4.
Investigating the structure-property relationship of bacterial PHA block copolymers.
J Biotechnol
; 132(3): 296-302, 2007 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17566581
5.
Bacterial synthesis of PHA block copolymers.
Biomacromolecules
; 7(6): 1904-11, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16768413